Theo-dur
Drug - Theo-dur
The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Theophylline
Multiple ingredients are in alphabetical order.
Strength -
200MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.
Applicant -
SCHERING
The firm name holding legal responsibility for Theo-dur. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
086998
The FDA assigned number to Theo-dur. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Theo-dur. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Theo-dur was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Theo-dur. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Theo-dur is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Schering Corp
The full name of the firm holding legal responsibility for the new application of Theo-dur.
Theo-dur
Quibron-t/sr 300mg Tablet, Extended Release; Oral Sustaire 100mg Tablet, Extended Release; Oral Sustaire 300mg Tablet, Extended Release; Oral Theochron 100mg Tablet, Extended Release; Oral Theochron 200mg Tablet, Extended Release; Oral Theochron 300mg Tablet, Extended Release; Oral Theo-dur 100mg Tablet, Extended Release; Oral Theo-dur 200mg Tablet, Extended Release; Oral Duraphyl 300mg Tablet, Extended Release; Oral Labid 250mg Tablet, Extended Release; Oral
NewDrugInformation
|